Cargando…
Neuromuscular blocking agents in the intensive care unit
Neuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit. If necessary, monitoring protocols should be established to avo...
Autores principales: | Rodríguez-Blanco, Jonathan, Rodríguez-Yanez, Tomás, Rodríguez-Blanco, Jesús Daniel, Almanza-Hurtado, Amilkar José, Martínez-Ávila, María Cristina, Borré-Naranjo, Diana, Acuña Caballero, María Camila, Dueñas-Castell, Carmelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528036/ https://www.ncbi.nlm.nih.gov/pubmed/36173012 http://dx.doi.org/10.1177/03000605221128148 |
Ejemplares similares
-
Intensive Care Unit Acquired Weakness Associated With Acute Severe Asthma
por: Borré-Naranjo, Diana, et al.
Publicado: (2022) -
Hypercapnia from Physiology to Practice
por: Almanza-Hurtado, Amilkar, et al.
Publicado: (2022) -
Dynamics of dengue and SARS-COV-2 co-infection in an endemic area of Colombia
por: Acosta-Pérez, Tomás, et al.
Publicado: (2022) -
Lazarus Phenomenon: Return of Spontaneous Circulation After Cessation of Prolonged Cardiopulmonary Resuscitation in a Patient With COVID-19
por: Martinez-Ávila, Maria Cristina, et al.
Publicado: (2021) -
Pneumomediastinum and Pneumothorax Following Non-invasive Respiratory Support in Patients With Severe COVID-19 Disease
por: Gutierrez-Ariza, Juan Camilo, et al.
Publicado: (2021)